GLAUCOMA EYE DROPS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Glaucoma Eye Drops Market - Overview Global Glaucoma Eye Drops Market, by Drug Type (Prostaglandin analogs, Beta blockers, Alpha agonists, Carbonic Anhydrase Inhibitors (CAIs), Combined Medications and Others (rho-kinase inhibitor, Cholinergic agonist)), by Disease Indication (Angle-closure Glaucoma and Open-angle Glaucoma), By Distribution Channel (Hospital Pharmacy Retail Pharmacy and Online Pharmacy), by Composition (Preservative Free, BAK-Based and Non BAK-Based Preservatives ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,360.1 million in 2020 and is expected to exhibit a CAGR of 7.0% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. Key players in the market have a number of drugs undergoing clinical trials for treatment of glaucoma and are expected to receive approval in the near future. The robust pipeline of glaucoma medications is expected to drive growth of global glaucoma eye drops market in the near future. For instance, in January 2019, Santen Pharmaceutical Co., Ltd. started a clinical trial on drug candidate DE-111A (that is a preservative-free, clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost and 5.0mg of timolol in 1mL) for the treatment of open-angle glaucoma, and ocular hypertension. The clinical trial included 324 patients. This clinical trial is in phase 3 and is expected to complete by the end of June 2020. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/glaucoma-eye-drops-market-3984 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION This study is to evaluate the safety and efficacy of Levobetaxolol in Chinese patients with glaucoma. This study included 366 Chinese patients with glaucoma. The clinical trial is in phase 3 and is expected to be completed by December 2021. There have been several developments in glaucoma medications in the recent past. Therefore, robust pipeline for treatment of glaucoma is expected to boost the glaucoma eye drops market growth in the near future. Browse 25 Market Data Tables and 28 Figures spread through 144 Pages and in-depth TOC on Glaucoma Eye Drops Market, by Drug Type (Prostaglandin analogs, Beta blockers, Alpha agonists, Carbonic Anhydrase Inhibitors (CAIs), Combined Medications and Others (rho-kinase inhibitor, Cholinergic agonist)), by Disease Indication (Angle-closure Glaucoma and Open-angle Glaucoma), By Distribution Channel (Hospital Pharmacy Retail Pharmacy and Online Pharmacy), by Composition (Preservative Free, BAK-Based and Non BAK-Based Preservatives ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)Forecast to 2027" Key Takeaways of the Glaucoma Eye Drops Market: The global glaucoma eye drops market is expected to exhibit a CAGR of 7.0% during the forecast period (2020-2027) owing to the robust product pipeline for treatment of glaucoma. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3984 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Similarly, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd., China in November 2015, initiated a clinical trial with Levobetaxolol eye drops for treatment of primary open-angle glaucoma and ocular hypertension. Among drug type, the consumables segment is expected to hold a major revenue share in 2027 owing to product approvals by regulatory bodies. For instance, in November 2017, Bausch Health, a global eye health company, and Nicox S.A., an international ophthalmic company, announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for VYZULTA (latanoprostene bunod ophthalmic solution, 0.024%) for glaucoma. Major players operating in the global glaucoma eye drops market are Merck & Co., Inc., Allergan Plc. Novartis AG. Teva Pharmaceutical Industry, Pfizer, Inc., Bausch & Lomb Inc., Inotek Pharmaceutical, Jadran-galenski laboratorij d.d., Aerie Pharmaceutical, and Mylan N.V. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3984
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
© Coherent market Insights. All Rights Reserved